TipRanks
Advertisement
Advertisement
Chemours initiated with an Equal Weight at Barclays
PremiumThe FlyChemours initiated with an Equal Weight at Barclays
7d ago
Chemours price target lowered to $16 from $18 at UBS
Premium
The Fly
Chemours price target lowered to $16 from $18 at UBS
14d ago
Chemours price target lowered to $18 from $20 at Mizuho
Premium
The Fly
Chemours price target lowered to $18 from $20 at Mizuho
19d ago
The Chemours Company Lawsuit: Former CEO Mark Newman Seeks Dismissal of Investor Claims
PremiumClass ActionThe Chemours Company Lawsuit: Former CEO Mark Newman Seeks Dismissal of Investor Claims
2M ago
Chemours Earnings Call: Pricing Strength Amid Headwinds
Premium
Company Announcements
Chemours Earnings Call: Pricing Strength Amid Headwinds
2M ago
Chemours price target lowered to $17 from $19 at Goldman Sachs
Premium
The Fly
Chemours price target lowered to $17 from $19 at Goldman Sachs
2M ago
Chemours downgraded to Neutral from Buy at UBS
PremiumThe FlyChemours downgraded to Neutral from Buy at UBS
2M ago
Chemours price target lowered to $24 from $30 at Truist
Premium
The Fly
Chemours price target lowered to $24 from $30 at Truist
2M ago
Chemours price target lowered to $22 from $26 at RBC Capital
Premium
The Fly
Chemours price target lowered to $22 from $26 at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―